Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02
Published March 12, 2014 · Recall initiated: January 24, 2014
Summary
FDA records drug Class II recall D-1093-2014, published March 12, 2014 and initiated January 24, 2014. Recalling firm: Teva Pharmaceuticals USA; Status: Terminated; Reported quantity: 2494 capsules; Lot: Lot # 34017426A, Exp. 10/16. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
What to do
Voluntary: Firm initiated · Letter
Get an email if HYDROXYZINE PAMOATE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- HYDROXYZINE PAMOATE
- Manufacturer
- Teva Pharmaceuticals USA
- Distributor
- Nationwide.
- UPC
- 0305550302025
- Lot
- Lot # 34017426A, Exp. 10/16.
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAHydrOXYzine Pamoate Capsules, USP, 50 mg, 100-count bottle, Rx only, MFG: Sandoz Pharma, NDC 0185-0615-01June 15, 2022
- FDATeva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals,March 12, 2014
- FDATeva Ethambutol Hydrochloride Tablets, USP, 400 mg, 100- count bottle, Rx Only,Distributed by TevaMarch 12, 2014
- FDATeva Dextroamphetamine Saccharate, Amphetamine Asparate, Dextroamphetamine Sulfate and Amphetamine SulfateMarch 12, 2014
- FDAAlprazolam Extended-Release Tablets, USP, 3 mg, 60-count tablets per bottle, Rx only, Manufactured by: ActavisMarch 12, 2014
- FDAMedtronic Everest 20cc Inflation Device; Model Number and Catalog Number: AC2205P The Everest 20cc InflationMarch 5, 2014
Questions about this recall
Was Teva Hydroxyzine Pamoate Capsules, USP, 100 mg, 100- count bottle,Rx only, Distributed by Teva Pharmaceuticals USA, Sellersville, PA. NDC 0555-0324-02 recalled?
Yes. FDA published recall D-1093-2014 on March 12, 2014. Reported hazard: CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 100 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: HYDROXYZINE PAMOATE. UPC: 0305550302025.